Bullish Analyst Perspective: L Brands (LB)
Post# of 120
Posted On: 10/10/2015 2:16:08 PM
Research analysts at Telsey Advisory Group raised their price target on shares of L Brands, Inc. (LB) from $104.00 to $110.00 while maintaining an Outperform rating.
L Brands posted September 2015 net sales of $919.9 million, an 8% increase year over year
L Brands, through Victoria's Secret, PINK, Bath & Body Works, La Senza and Henri Bendel, is an international company.
**
PAREXEL International Corp. (PRXL) was upgraded by stock analysts at Robert W. Baird from a Neutral to an Outperform rating with a price target of $75.00 per share.
PAREXEL, a leading global biopharmaceutical services organization, will release its first quarter fiscal 2016 financial results on Wednesday, October 28th, 2015 after the close of the stock market.
**
Brokerage firm Credit Suisse initiated coverage on Zimmer Biomet Holdings, Inc. (ZBH) stock with an Outperform rating and a price target of $107.00
Zimmer Biomet is a global leader in musculoskeletal healthcare
**
Investment analysts at Maxim Group initiated coverage on shares of Check-Cap Ltd. (CHEK) with a Buy rating and a price target of $18.00
Check-Cap is a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening
**
Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWEWorld Finance is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read Full Disclaimer at www.crweworld.com/finance_disclaimer
L Brands posted September 2015 net sales of $919.9 million, an 8% increase year over year
L Brands, through Victoria's Secret, PINK, Bath & Body Works, La Senza and Henri Bendel, is an international company.
**
PAREXEL International Corp. (PRXL) was upgraded by stock analysts at Robert W. Baird from a Neutral to an Outperform rating with a price target of $75.00 per share.
PAREXEL, a leading global biopharmaceutical services organization, will release its first quarter fiscal 2016 financial results on Wednesday, October 28th, 2015 after the close of the stock market.
**
Brokerage firm Credit Suisse initiated coverage on Zimmer Biomet Holdings, Inc. (ZBH) stock with an Outperform rating and a price target of $107.00
Zimmer Biomet is a global leader in musculoskeletal healthcare
**
Investment analysts at Maxim Group initiated coverage on shares of Check-Cap Ltd. (CHEK) with a Buy rating and a price target of $18.00
Check-Cap is a clinical stage medical diagnostics company engaged in the development of an ingestible capsule for preparation-free, colorectal cancer screening
**
Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWEWorld Finance is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read Full Disclaimer at www.crweworld.com/finance_disclaimer
(0)
(0)